Multiple sclerosis (MS) is a chronic, immune-mediated demyelinating disease of the central nervous system that disrupts nerve-signal transmission between the brain and body. It leads to symptoms such as visual impairment, muscle weakness, fatigue, and cognitive dysfunction. MS manifests in relapsing-remitting or progressive forms, affecting millions worldwide.

The Multiple Sclerosis session explores the immunopathogenesis, diagnosis, and treatment of MS through the latest research and clinical approaches. Scientists focus on myelin destruction, neuroinflammation, and axonal damage caused by aberrant immune responses.

At the Multiple Sclerosis Conference, neurologists, immunologists, and molecular biologists present breakthroughs in understanding the roles of T-cells, B-cells, and cytokines in disease progression. Cutting-edge discussions highlight biomarkers for early detection, MRI-based monitoring, and next-generation therapies such as monoclonal antibodies and remyelination drugs.

This session brings together global MS researchers, clinicians, and rehabilitation experts to discuss comprehensive management—from disease-modifying treatments to lifestyle and psychological interventions. Emphasis is placed on personalized medicine, symptom management, and neurorehabilitation for long-term patient care.

Emerging studies in Neuroimmunology and Neuroinflammation reveal novel immune targets and molecular pathways, opening new horizons for precision immunotherapy.